My 10-share stock market portfolio for future growth

I have invested in a stock market portfolio of FTSE 350 shares that I expect to continue outperforming these indices over the medium to long term.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Inflation is rampant worldwide. Nevertheless, I believe that — in these difficult times — stock markets still offer the best investment hedge against inflation and excellent long-term return potential for carefully selected shares.

My portfolio

FTSEShareCodeMarket cap (£bn)IndustryYTD % performanceOne-year % performanceThree-year % performance
100AstraZenecaAZN175.8Pharmaceuticals24.1526.5147.23
250BeazleyBEZ3.5Insurance22.1345.240.00
100BunzlBNZL10.6Distribution, logistics-0.358.3342.82
250CapricornCNE0.7Oil, Gas Exploration25.9722.3942.21
100GlencoreGLEN64.9Mining & Trading30.3649.76108.12
250HuntingHTG0.5Energy Industry supplier68.4439.02-37.64
250IndiviorINDV2.1Pharmaceuticals12.0645.31377.45
250MediclinicMDC3.7Health55.5658.1246.85
250SercoSRP2.1Government Services32.1733.5621.93
100SSESSE19.4Power Generation2.512.3046.87
PortfolioAs at 31.8.2227.3033.0569.58

On an equal invested value basis, the portfolio has grown by 69.6% over the past three years (+19.2% per annum). While past performance is no guarantee of future performance, medium to long term I expect the overall portfolio to outperform the FTSE 100 and FTSE 250 indices.

One or two of the stocks may disappoint. Hence, I will actively manage the portfolio and substitute any stocks for which the prospects deteriorate.

AstraZeneca

A British-Swedish multinational pharmaceutical and biotechnology company. It was at the forefront of the rush to develop and distribute a vaccine for Covid-19. Its innovative medicines are used by millions of patients worldwide.

Beazley

A British parent company of worldwide insurance businesses. It underwrites a diverse book of insurance and reinsurance for clients and is a market leader in many of its chosen lines.

Bunzl

A British multinational distribution and outsourcing company. Over 50% of its business is in the food service and food retail sectors.

Capricorn Energy  (previously Cairn Energy)

A British oil and gas exploration and development company. Despite Britain’s net zero objectives, as green billionaire Elon Musk says, “civilization would crumble” if the world stops drilling for oil and gas.

Glencore

An Anglo-Swiss company. One of the world’s largest globally diversified natural resource businesses, being both a mining company and the world’s largest commodities trading firm.

Hunting

A British-based supplier to the oil and gas industry.

Indivior  

A global pharmaceutical company specialising in developing medicines to treat substance use disorders and serious mental illnesses.

Mediclinic International

An international private hospital group with hospitals in South Africa, Namibia, Switzerland and the United Arab Emirates.

Serco

A British contractor for the supply of Government services, primarily in the health, transport, justice, immigration, space, and defense sectors. 55% of the company’s revenue is generated outside the UK.

SSE

Formerly Southern and Scottish Energy, SSE is a multinational energy company that operates UK power stations and offshore wind farms and has a hydroelectric plant in Scotland.

Ian Benfield has positions in AstraZeneca, Beazley, Bunzl, Capricorn Energy, Glencore, Hunting, Indivior, Mediclinic, Serco and SSE. The Motley Fool UK has recommended Bunzl. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Abstract 3d arrows with rocket
Investing Articles

Up 25% YTD! Is this red-hot penny stock still ‘cheap’?

This penny stock has been on fire in 2026. Ken Hall takes a closer look at the investment story behind…

Read more »

Man smiling and working on laptop
Investing Articles

Stock market correction? A passive income opportunity!

Looking to turbocharge your passive income? The stock market correction could be a once-in-a-decade chance to do just that, says…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Are investors running scared of Babcock and BAE Systems shares?

BAE Systems shares have had a brilliant run, and other UK defence stocks have been flying too. But Harvey Jones…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

As the FTSE 100 falls, savvy investors are looking for stocks to buy for the rebound

Many FTSE stocks have now fallen 10% or more from their 2026 highs. For long-term investors, exciting opportunities are emerging.

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

Should investors consider buying resilient Admiral Group and Tesco shares as markets wobble?

Harvey Jones is impressed by how Tesco shares have held up in the current market volatility, while Admiral has been…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Down 15% in a month and yielding 7.5%! Should I buy even more of my favourite dividend stock?

Harvey Jones says this brilliant FTSE 100 dividend stock is suddenly cheaper due to recent market volatility. And the yield…

Read more »

Abstract bull climbing indicators on stock chart
Growth Shares

3 growth shares for an ISA that have beaten the FTSE 100 for the past 5 years

Jon Smith points out several growth shares that have outperformed the broader market over a long period of time, with…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

Time’s running out for our 2025/26 Stocks and Shares ISA plans!

Never mind the stock market wobble, it's time to turn our attention to our Stocks and Shares ISA investments for…

Read more »